Northwest Biotherapeutics, a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, reported that yesterday on June 4, 2022, in the Industry Expert Theater during the ASCO 2022 conference, Dr. Marnix Bosch made a presentation discussing the Company's DCVax-L technology for personalized dendritic cell vaccines…
… The Industry Expert Theater is not an official event of the ASCO Annual Meeting. It is not sponsored, endorsed or accredited by ASCO, CancerLinq, or Conquer Cancer the ASCO Foundation. It is not CME-accredited.
Ha! The Industry Expert Theater is a venue for infomercials. Note the use of the diversionary word, “during” in the first paragraph above.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”